0001209191-23-005788.txt : 20230131
0001209191-23-005788.hdr.sgml : 20230131
20230131180727
ACCESSION NUMBER: 0001209191-23-005788
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230127
FILED AS OF DATE: 20230131
DATE AS OF CHANGE: 20230131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hermans Kate
CENTRAL INDEX KEY: 0001956523
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40505
FILM NUMBER: 23574050
MAIL ADDRESS:
STREET 1: C/O AMBRX BIOPHARMA INC.
STREET 2: 10975 TORREY PINES ROAD
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ambrx Biopharma Inc.
CENTRAL INDEX KEY: 0001836056
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 571147346
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10975 NORTH TORREY PINES ROAD
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 729-3339
MAIL ADDRESS:
STREET 1: 10975 NORTH TORREY PINES ROAD
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-27
0
0001836056
Ambrx Biopharma Inc.
AMAM
0001956523
Hermans Kate
C/O AMBRX BIOPHARMA INC.
10975 TORREY PINES ROAD
LA JOLLA
CA
92037
1
0
0
0
Stock Option (right to buy)
0.38
2023-01-27
4
D
0
210000
D
2032-06-29
Ordinary Shares
210000
0
D
Stock Option (right to buy)
0.28
2023-01-27
4
A
0
210000
A
2032-06-29
Ordinary Shares
210000
210000
D
Stock Option (right to buy)
0.43
2023-01-27
4
D
0
105000
D
2032-07-07
Ordinary Shares
105000
0
D
Stock Option (right to buy)
0.28
2023-01-27
4
A
0
105000
A
2032-07-07
Ordinary Shares
105000
105000
D
Stock Option (right to buy)
0.35
2023-01-27
4
D
0
210000
D
2022-12-15
2032-08-14
Ordinary Shares
210000
0
D
Stock Option (right to buy)
0.28
2023-01-27
4
A
0
210000
A
2022-12-15
2032-08-14
Ordinary Shares
210000
210000
D
The Ordinary Shares subject to the option vest in thirty-six equal monthly installments following June 30, 2022.
The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents seven Ordinary Shares of the Issuer.
The option held by the reporting person was amended to reduce the exercise price.
The Ordinary Shares subject to the option will vest on the earlier of (i) July 8, 2023, or (ii) the day immediately prior to the date of the next Annual Grant Date as defined in the Company's Non-Employee Director Compensation Policy.
/s/ Sonja Nelson, Attorney-in-Fact for Kate Hermans
2023-01-31